findmyKOL
Clinical trialNCT01970007CompletedInterventional

VIVO Clinical Study

SponsorCook Research IncorporatedEnrollment243Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Taiwan
  • Taipei Medical University Wan Fang Hospital

    Taipei, Taiwan

United States
  • University of Alabama Birmingham Hospital

    Birmingham, Alabama, United States

  • Arrowhead Hospital

    Glendale, Arizona, United States

  • Littleton Adventist Hospital

    Littleton, Colorado, United States

  • Yale-New Haven Hospital

    New Haven, Connecticut, United States

  • Southern Connecticut Vascular Center - Norwalk Hospital

    Norwalk, Connecticut, United States

  • Christiana Care Health Systems

    Newark, Delaware, United States

  • Florida Pepin Heart Institute

    Tampa, Florida, United States

  • Piedmont Hospital

    Atlanta, Georgia, United States

  • Methodist Hospital of Indiana

    Indianapolis, Indiana, United States

  • St. Vincent Medical Group

    Indianapolis, Indiana, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • University of Louisville - Norton Hospital

    Louisville, Kentucky, United States

  • Shady Grove Adventist

    Rockville, Maryland, United States

  • University of Michigan Health System

    Ann Arbor, Michigan, United States

  • Barnes Jewish Hospital Plaza

    St Louis, Missouri, United States

  • Mercy Hospital

    St Louis, Missouri, United States

  • Chi Health St. Elizabeth

    Lincoln, Nebraska, United States

  • Holy Name Medical Center

    Teaneck, New Jersey, United States

  • New York University - Langone Medical Center

    New York, New York, United States

  • Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Rex Hospital

    Raleigh, North Carolina, United States

  • Good Samaritan Hospital

    Cincinnati, Ohio, United States

  • Promedica - Jobst Vascular Institute

    Toledo, Ohio, United States

  • Oklahoma State University Medical Center

    Tulsa, Oklahoma, United States

  • Temple University Hospital

    Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Cardiothoracic and Vascular Surgeons

    Austin, Texas, United States

  • Utah Valley Regional Medical Center

    Provo, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Dec 2013
Primary completion
20 Nov 2017
Completion
20 Nov 2019
Last update posted
8 Apr 2021
Registered enrollment
243
Registry id
NCT01970007

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.